No increased risk of ADHD following benzodiazepine/z-drug hypnotic use in pregnancy
Researchers affiliated to the PharmacoEpidemiology and Drug Safety Research Group at the University of Oslo, led by ENTIS member Professor Hedvig Nordeng, have published a large comparative cohort study investigating childhood ADHD risks following maternal benzodiazepine/z-drug hypnotic use in pregnancy. The full study sample consisted of more than 82,000 singleton pregnancies, with 681 offspring exposed to benzodiazepines or z-drug hypnotics in utero. The results are reassuring; after controlling for confounding, there was no evidence for an increased risk of ADHD following exposure either at any time in pregnancy, after exposure in early pregnancy or in mid/late pregnancy. For more information, see here.